| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 18.06B | 20.06B | 20.43B | 20.18B | 19.44B | 19.14B |
| Gross Profit | 6.34B | 7.18B | 7.03B | 6.22B | 5.99B | 6.82B |
| EBITDA | 3.26B | 3.98B | 3.07B | 3.38B | 3.25B | 3.98B |
| Net Income | 1.97B | 2.54B | 1.76B | 1.93B | 1.81B | 2.35B |
Balance Sheet | ||||||
| Total Assets | 16.89B | 16.55B | 17.34B | 17.97B | 17.84B | 17.52B |
| Cash, Cash Equivalents and Short-Term Investments | 617.00M | 1.02B | 1.09B | 427.00M | 270.00M | 303.00M |
| Total Debt | 6.47B | 7.92B | 8.11B | 8.55B | 8.70B | 8.50B |
| Total Liabilities | 15.56B | 15.57B | 16.28B | 17.27B | 17.10B | 16.65B |
| Stockholders Equity | 1.33B | 840.00M | 915.00M | 547.00M | 514.00M | 626.00M |
Cash Flow | ||||||
| Free Cash Flow | 2.41B | 2.51B | 2.78B | 1.86B | 1.72B | 2.51B |
| Operating Cash Flow | 2.62B | 3.23B | 3.54B | 2.73B | 2.73B | 3.73B |
| Investing Cash Flow | -194.00M | -100.00M | -418.00M | -785.00M | -1.06B | -2.31B |
| Financing Cash Flow | -686.00M | -3.17B | -2.37B | -1.76B | -1.70B | -1.57B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| ― | $345.88B | 21.61 | 31.90% | 2.78% | 1.23% | 17.97% | |
| ― | $20.72B | 27.16 | 18.59% | 1.39% | 1.45% | 42.04% | |
| ― | $60.44B | 21.01 | 450.35% | 2.67% | -0.05% | 2.49% | |
| ― | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
| ― | $33.94B | 17.32 | 136.87% | 4.89% | -10.04% | -23.41% | |
| ― | $13.29B | 16.75 | 249.61% | 4.37% | 0.16% | 191.17% | |
| ― | $27.58B | 19.52 | 13.56% | 5.72% | -2.15% | 26.65% |
On November 2, 2025, Kimberly-Clark Corporation entered into a merger agreement with Kenvue Inc., aiming to acquire all outstanding shares of Kenvue in a transaction valued at approximately $48.7 billion. This merger, which combines two iconic American companies, is expected to create a global health and wellness leader with a portfolio of complementary products, including 10 billion-dollar brands. The transaction is anticipated to generate significant synergies, with an estimated $2.1 billion in run-rate synergies and an accretive impact on Kimberly-Clark’s adjusted EPS by the second year. The merger is expected to close in the second half of 2026, pending shareholder and regulatory approvals.
The most recent analyst rating on (KMB) stock is a Hold with a $132.00 price target. To see the full list of analyst forecasts on Kimberly Clark stock, see the KMB Stock Forecast page.
Kimberly-Clark’s recent earnings call painted a picture of robust growth driven by innovation and strategic market positioning, particularly in the diaper segment. Despite facing competitive pressures and a challenging consumer environment, the company remains well-positioned to achieve its long-term margin targets. However, there are concerns about potential earnings dilution from the IFP joint venture.
Kimberly-Clark Corporation, a leading player in the personal care industry, is renowned for its trusted brands like Huggies and Kleenex, which are staples in households across more than 175 countries. The company focuses on delivering sustainable products that cater to everyday needs while maintaining a strong commitment to environmental and community well-being.